API australian pharmaceutical industries limited

Disagree. "one would have to look at the cash flow statement"......

  1. 1,158 Posts.
    lightbulb Created with Sketch. 186
    Disagree. "one would have to look at the cash flow statement"... Yep, agree, maybe take your own advice next time.

    A couple of points for you to consider:

    Income statement - What caused the -$87k reduction in NPAT?
    - Gross profit -$43k - Given store closures I dont see how you can't blame this on Covid
    - Administration fees +20k - Please explain warranted
    -
    One off impairment (Soul Pattisson Chemists) +37k - Please explain warranted but this is a non-cash expense.

    Cash Flow Statement

    As a shareholder, how can you be dissapointed with a $180k increase in cash inflows from operations AND net cashflows from operations increasing by $204k.

    Considering the broader economic landscape, this is a great result IMO. Yes there are clear improvements from management that are required (for one, shareholder comms are appauling), however I am liking what I see from a cash generation perspective.
    https://hotcopper.com.au/data/attachments/2586/2586328-9a11a4e30aaaf46fde223547513f7860.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.